VANGUARD GROUP INC - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 46 filers reported holding PYXIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q2 2024$6,820,070
+14.2%
2,060,444
+47.0%
0.00%
Q1 2024$5,970,070
+153.8%
1,401,425
+7.3%
0.00%
Q4 2023$2,352,033
+3.7%
1,306,685
+14.6%
0.00%
Q3 2023$2,269,084
-19.2%
1,140,243
+4.0%
0.00%
Q2 2023$2,806,910
-34.1%
1,096,449
+3.2%
0.00%
Q1 2023$4,260,821
+246.4%
1,062,549
+15.8%
0.00%
Q4 2022$1,229,888
-31.9%
917,827
+0.0%
0.00%
Q3 2022$1,807,000
-10.6%
917,384
+8.0%
0.00%
Q2 2022$2,021,000
-4.9%
849,080
+61.3%
0.00%
Q1 2022$2,126,000
-62.7%
526,309
+1.2%
0.00%
Q4 2021$5,707,000520,2980.00%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
SUPERSTRING CAPITAL MANAGEMENT LP 484,443$1,603,5062.02%
STEMPOINT CAPITAL LP 1,202,675$3,980,8541.17%
Blue Owl Capital Holdings LP 1,046,025$3,462,3430.96%
Ikarian Capital, LLC 1,662,408$5,502,5710.96%
Deep Track Capital, LP 4,184,100$13,849,3710.41%
Decheng Capital LLC 326,810$1,081,7410.33%
Yu Fan 69,303$229,3930.30%
Cable Car Capital LLC 61,606$203,9160.22%
Ikarian Capital, LLC 3,586$1,186,9660.21%
Laurion Capital Management LP 3,861,179$12,780,5020.15%
View complete list of PYXIS ONCOLOGY INC shareholders